1999
DOI: 10.1023/a:1015037800903
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: Based on these molecular descriptors, the quinazolinone derivative MCI-176 is predicted to be a potential ligand of the diltiazem binding site.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2005
2005
2009
2009

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 22 publications
0
1
0
Order By: Relevance
“…Subsequently, we applied molecular modeling techniques in order to explore the high affinity of the new structures toward the diltiazem binding site and to confirm or refine the recent hypotheses concerning its structural features. In fact, in recent years several SAR studies and quantitative models have been proposed in order to understand the binding mode of calcium antagonists and to propose receptor site schemes for all the three major antagonist classes, that is, BTZs, DHPs, , and PAAs . Despite the abundance of models regarding DHP-type, little information is available concerning the binding mode of BTZ diltiazem analogues.…”
Section: Introductionmentioning
confidence: 99%
“…Subsequently, we applied molecular modeling techniques in order to explore the high affinity of the new structures toward the diltiazem binding site and to confirm or refine the recent hypotheses concerning its structural features. In fact, in recent years several SAR studies and quantitative models have been proposed in order to understand the binding mode of calcium antagonists and to propose receptor site schemes for all the three major antagonist classes, that is, BTZs, DHPs, , and PAAs . Despite the abundance of models regarding DHP-type, little information is available concerning the binding mode of BTZ diltiazem analogues.…”
Section: Introductionmentioning
confidence: 99%